Zymeworks

-$0.61 (-1.87%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Zymeworks and other ETFs, options, and stocks.

About ZYME

Zymeworks, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development and commercialization of biotherapeutics. Its product, ZW25 and ZW49 are a bispecific antibody that cans two non-overlapping epitopes.

CEO
Ali Tehrani
Employees
355
Headquarters
Vancouver, British Columbia
Founded
2003

ZYME Key Statistics

Market Cap
1.61B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
399.69K
High Today
$32.66
Low Today
$31.85
Open Price
$32.65
Volume
411.34K
52 Week High
$59.03
52 Week Low
$24.82

ZYME Earnings

-$1.43
-$0.95
-$0.48
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 13, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure